Beam Therapeutics (BEAM) Beats Q4 Earnings Estimates by $1.02
Beam Therapeutics (NASDAQ:BEAM) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Read more
